{"id":171804,"date":"2026-07-01T11:42:13","date_gmt":"2026-07-01T11:42:13","guid":{"rendered":"https:\/\/www.m3globalresearch.com\/blog\/?p=171804"},"modified":"2026-07-01T15:08:51","modified_gmt":"2026-07-01T15:08:51","slug":"three-tools-using-ctdna-tissue-testing-imaging-together","status":"publish","type":"post","link":"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/","title":{"rendered":"Three Tools, Different Questions: Using ctDNA, Tissue Testing, and Imaging Together"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"171804\" class=\"elementor elementor-171804\" data-elementor-settings=\"{&quot;ha_cmc_init_switcher&quot;:&quot;no&quot;}\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c98ce8f e-flex e-con-boxed e-con e-parent\" data-id=\"c98ce8f\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-73b8ae8 e-con-full e-flex e-con e-child\" data-id=\"73b8ae8\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9cd2eb6 elementor-widget elementor-widget-text-editor\" data-id=\"9cd2eb6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>ctDNA, tissue testing, and imaging are sometimes presented as competing approaches in oncology. In practice, each is built to answer a different clinical question, and understanding those differences, rather than ranking the tools against each other, is what allows them to be used well together.<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-123b0b7 elementor-widget elementor-widget-text-editor\" data-id=\"123b0b7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>In modern oncology, the relevant question is rarely which single test is best. It is which combination of tests answers the question in front of the clinician at that moment. Tissue testing, sometimes called tissue biopsy, remains the only method that provides direct histomorphologic diagnosis, tumour grade, and protein-level markers obtained through immunohistochemistry.<\/p>\n<p>\u00a0<\/p>\n<p>Circulating tumour DNA, often called liquid biopsy and collected through a simple blood draw, offers a minimally invasive window into the genomic profile of the tumour and can be repeated serially to track molecular change over time. Imaging answers a different question again: where the disease is located, how extensive it is, and how that anatomic burden is changing. None of the three can substitute for what the others are designed to detect. A tissue sample cannot show whether a lesion outside the biopsied site harbours a resistance mutation. ctDNA cannot confirm histologic subtype or substitute for tumour grading performed by a pathologist. Imaging cannot identify a targetable molecular alteration. Treating any one of them as sufficient on its own narrows the clinical picture rather than sharpening it.<\/p>\n<p>\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-59e25cf elementor-widget elementor-widget-text-editor\" data-id=\"59e25cf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Major oncology bodies have converged on this complementary framing. Updated NCCN guidance for non-small cell lung cancer<a href=\"https:\/\/www.hmpgloballearningnetwork.com\/site\/jcp\/jcp-special-report\/2024-nccn-clinical-practice-guidelines-oncology-nccn-guidelines-r\">*<\/a> recommends broad-based testing using combinations of tissue and plasma testing, run concurrently where possible, with retesting via a complementary method if initial results are negative or inconclusive.\u00a0The International Association for the Study of Lung Cancer<a href=\"https:\/\/www.jto.org\/article\/S1556-0864(21)02284-X\/fulltext\">*<\/a>\u00a0has described liquid biopsy as the preferred approach in some clinical settings, while remaining complementary to tissue testing in others. Neither position treats one modality as a wholesale replacement for another; the practical task for clinicians is matching the right tool, or combination of tools, to the specific question at hand.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<p class=\"e-paragraph-base\" data-interaction-id=\"9bb262f\" data-e-type=\"widget\" data-id=\"9bb262f\"><\/p>\n\t\t\t\t<div class=\"elementor-element elementor-element-7cf9e89 elementor-widget elementor-widget-text-editor\" data-id=\"7cf9e89\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Continue reading to explore how each tool answers a different question, where their blind spots lie, and how they work together across the patient journey:<\/p><ul><li><strong><a href=\"#what-each-tool-answers\">What Each Tool Is Built to Answer<\/a><\/strong><\/li><li><strong><a href=\"#tools-diverge\">Where the Tools Diverge: Strengths and Blind Spots<\/a><\/strong><\/li><li><strong><a href=\"#working-together-patient-journey\">Working Together Across the Patient Journey<\/a><\/strong><\/li><li><strong><a href=\"#practical-framework-mdt\">A Practical Framework for Multidisciplinary Teams<\/a><\/strong><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5b804b3 elementor-widget elementor-widget-menu-anchor\" data-id=\"5b804b3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"menu-anchor.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-menu-anchor\" id=\"what-each-tool-answers\"><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b39103c elementor-widget elementor-widget-spacer\" data-id=\"b39103c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f6b5988 elementor-widget__width-initial elementor-widget elementor-widget-image\" data-id=\"f6b5988\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"760\" height=\"300\" src=\"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ctDNA-2-scaled.jpeg?resize=760%2C300&amp;ssl=1\" class=\"attachment-rta_thumb_cropped_760x300 size-rta_thumb_cropped_760x300 wp-image-171867\" alt=\"ctDNA, tissue biopsy and cancer imaging each support cancer diagnosis by answering different clinical questions together.\" srcset=\"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ctDNA-2-scaled.jpeg?resize=760%2C300&amp;ssl=1 760w, https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ctDNA-2-scaled.jpeg?zoom=2&amp;resize=760%2C300&amp;ssl=1 1520w, https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ctDNA-2-scaled.jpeg?zoom=3&amp;resize=760%2C300&amp;ssl=1 2280w\" sizes=\"(max-width: 760px) 100vw, 760px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ec159a1 elementor-widget elementor-widget-spacer\" data-id=\"ec159a1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1a6974e elementor-widget elementor-widget-heading\" data-id=\"1a6974e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">What Each Tool Is Built to Answer<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1ad237c elementor-widget elementor-widget-text-editor\" data-id=\"1ad237c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>Tissue Testing: Defining Tumour Biology<\/strong><\/p><p>Tissue testing answers the question of what the tumour actually is at a cellular and molecular level. Histopathological examination establishes diagnosis, subtype, and grade, while immunohistochemistry identifies protein-level markers that guide treatment selection. For patients with advanced cancer, treatment decisions guided by genomic profiling have traditionally been built on tissue, and despite the rise of blood-based testing,\u00a0tissue-derived profiling still anchors that decision-making at most centres<a href=\"https:\/\/www.annalsofoncology.org\/article\/S0923-7534(22)04147-3\/fulltext\">*<\/a>, remaining the only method that captures tumour architecture directly. Companion diagnostic assays tied to specific approved therapies are also generally validated on tissue, which keeps tissue testing central to treatment selection even as other tools expand.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fea9b4d elementor-widget elementor-widget-text-editor\" data-id=\"fea9b4d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>Circulating Tumour DNA (Liquid Biopsy): Tracking the Molecular Signal Over Time<\/strong><\/p>\n<p>\u00a0<\/p>\n<p>ctDNA answers a related but distinct question: what mutations are detectable in the blood right now, and how is that molecular signal changing.\u00a0An expert working group convened by ESMO<a href=\"https:\/\/www.annalsofoncology.org\/article\/S0923-7534(22)01721-5\/fulltext\">*\u00a0<\/a>reviewed the evidence base for these assays and concluded that, once their limitations are understood, well-validated and sufficiently sensitive ctDNA tests can reliably identify alterations suitable for targeted treatment and have a place in everyday clinical use. Because liquid biopsy requires only a blood draw, it can be repeated serially in a way that tissue sampling cannot, making it well suited to genotyping when rapid results are needed or when tissue is unavailable or unsafe to obtain.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fc0c180 elementor-widget elementor-widget-text-editor\" data-id=\"fc0c180\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>Imaging: Mapping Location, Extent, and Anatomic Change<\/strong><\/p>\n<p>\u00a0<\/p>\n<p>Imaging answers a question that neither tissue nor ctDNA is designed to address: where the disease is, how extensive it is, and how its anatomic burden is responding to treatment. Computed tomography, magnetic resonance imaging, and positron emission tomography remain the basis for staging, surgical and radiotherapy planning, and standardised response assessment. The framework most oncology teams rely on to judge treatment response,\u00a0Response Evaluation Criteria in Solid Tumours (RECIST)<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8252278\/\">*<\/a>, depends entirely on this anatomic information, and imaging also identifies which lesion is most accessible and representative for biopsy, a role neither of the other two tools can perform.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8445622 elementor-widget elementor-widget-menu-anchor\" data-id=\"8445622\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"menu-anchor.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-menu-anchor\" id=\"tools-diverge\"><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b9c8790 elementor-widget elementor-widget-spacer\" data-id=\"b9c8790\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<img decoding=\"async\" class=\"e-image-base \" data-interaction-id=\"850372b\" data-e-type=\"widget\" data-id=\"850372b\" id=\"171868\" src=\"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/tissue-biopsy-scaled.jpeg?resize=760%2C300&amp;#038;ssl=1\" width=\"760\" height=\"300\" srcset=\"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/tissue-biopsy-scaled.jpeg?resize=760%2C300&amp;ssl=1 760w, https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/tissue-biopsy-scaled.jpeg?zoom=2&amp;resize=760%2C300&amp;ssl=1 1520w, https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/tissue-biopsy-scaled.jpeg?zoom=3&amp;resize=760%2C300&amp;ssl=1 2280w\" alt=\"ctDNA, tissue biopsy and cancer imaging each support cancer diagnosis by answering different clinical questions together.\"\/>\t\t\t\t<div class=\"elementor-element elementor-element-25cf3f0 elementor-widget elementor-widget-spacer\" data-id=\"25cf3f0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d683d88 elementor-widget elementor-widget-heading\" data-id=\"d683d88\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Where the Tools Diverge: Strengths and Blind Spots<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-282c6f6 elementor-widget elementor-widget-text-editor\" data-id=\"282c6f6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>Sampling Bias in Tissue<\/strong><\/p><p>Tissue testing is constrained by the sample it is given. A single core biopsy reflects one site at one point in time, and because tumours vary genetically from one region to another and continue to change as they evolve,\u00a0that one sample can easily miss molecular features present elsewhere in the tumour or at other metastatic sites<a href=\"https:\/\/www.mdpi.com\/2072-6694\/14\/6\/1384\">*<\/a>. Repeat biopsies to address this are often invasive, costly, and not always feasible, particularly when disease is spread across multiple anatomic compartments.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-27e0383 elementor-widget elementor-widget-text-editor\" data-id=\"27e0383\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>The Blood-Brain Barrier Blind Spot for ctDNA<\/strong><\/p><p>ctDNA has its own structural limitation: the blood-brain barrier restricts the release of tumour-derived DNA into systemic circulation, so plasma ctDNA testing is comparatively insensitive for disease confined to the central nervous system. In glioma specifically,\u00a0plasma ctDNA testing returns a positive result in only a small minority of patients<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6986252\/\">*<\/a>, so a negative blood draw cannot be taken as reassurance that intracranial disease is absent. For any patient with suspected central nervous system involvement, imaging remains the necessary tool regardless of what plasma ctDNA shows.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c0fe205 elementor-widget elementor-widget-text-editor\" data-id=\"c0fe205\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>The Limits of Anatomic Response Criteria<\/strong><\/p><p>The blind spot for imaging lies in what anatomic size change can and cannot tell you. Because RECIST tracks dimensional change alone,\u00a0it was not built to register the functional or metabolic shifts that molecularly targeted agents and immunotherapy can produce well before, or even without, a measurable drop in tumour size<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8252278\/\">*<\/a>. Cytostatic agents that are biologically effective may not shrink a tumour on schedule, and new lesions appearing during immunotherapy can reflect transient inflammatory change rather than true progression, a distinction anatomic imaging alone is not designed to make.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3e76bb0 elementor-widget elementor-widget-menu-anchor\" data-id=\"3e76bb0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"menu-anchor.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-menu-anchor\" id=\"working-together-patient-journey\"><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e5758ba elementor-widget elementor-widget-spacer\" data-id=\"e5758ba\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3054d8a elementor-widget elementor-widget-image\" data-id=\"3054d8a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"760\" height=\"300\" src=\"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/cancer-imaging-scaled.jpeg?resize=760%2C300&amp;ssl=1\" class=\"attachment-rta_thumb_cropped_760x300 size-rta_thumb_cropped_760x300 wp-image-171869\" alt=\"ctDNA, tissue biopsy and cancer imaging each support cancer diagnosis by answering different clinical questions together.\" srcset=\"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/cancer-imaging-scaled.jpeg?resize=760%2C300&amp;ssl=1 760w, https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/cancer-imaging-scaled.jpeg?zoom=2&amp;resize=760%2C300&amp;ssl=1 1520w, https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/cancer-imaging-scaled.jpeg?zoom=3&amp;resize=760%2C300&amp;ssl=1 2280w\" sizes=\"(max-width: 760px) 100vw, 760px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-db8f2ee elementor-widget elementor-widget-spacer\" data-id=\"db8f2ee\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-df0d541 elementor-widget elementor-widget-heading\" data-id=\"df0d541\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Working Together Across the Patient Journey<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d6597ca elementor-widget elementor-widget-text-editor\" data-id=\"d6597ca\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>At Diagnosis and Initial Genotyping<\/strong><\/p><p>At diagnosis, the most efficient strategy is rarely sequential testing but concurrent use of tissue and plasma.\u00a0Guideline bodies now favour ordering tissue and plasma panels side by side rather than waiting on one before trying the other<a href=\"https:\/\/www.hmpgloballearningnetwork.com\/site\/jcp\/jcp-special-report\/2024-nccn-clinical-practice-guidelines-oncology-nccn-guidelines-r\">*<\/a>, and switching to the alternative method if either comes back negative or technically unsuccessful. Imaging contributes the staging information that determines what level of molecular testing is indicated in the first place, and identifies the lesion best suited for biopsy.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fc0e7cc elementor-widget elementor-widget-text-editor\" data-id=\"fc0e7cc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>During Treatment: Detecting Resistance Early<\/strong><\/p><p>Once treatment begins, ctDNA can flag an emerging resistance mutation before a lesion has grown enough to be visible on a scan, offering an early signal that something is changing at the molecular level. That signal still needs anatomic confirmation. A rising ctDNA level should prompt imaging to establish whether a measurable lesion corresponds to it before a treatment change is made, and in some cases a repeat tissue sample is needed to identify histologic transformation, such as small-cell transformation in EGFR-mutant lung cancer, that blood-based testing alone cannot detect.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-44211a7 elementor-widget elementor-widget-text-editor\" data-id=\"44211a7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>After Curative-Intent Therapy: Surveillance and Molecular Residual Disease<\/strong><\/p><p>After surgery with curative intent, ctDNA detection can precede imaging-confirmed recurrence by a considerable margin. Trials such as DYNAMIC in stage II colon cancer have shown that ctDNA status after surgery is associated with recurrence risk and have used ctDNA to guide adjuvant chemotherapy decisions, and ongoing prospective studies continue to define the role of ctDNA-based molecular residual disease testing across solid tumour types<a href=\"https:\/\/ascopost.com\/videos\/thematic-newsreels\/mrd-testing-recent-data-and-ongoing-efforts\/\">*<\/a>. Outside these trial settings, this remains an evolving application rather than a uniform standard, and imaging is still required to localise and confirm any signal before further intervention is planned.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-48604db elementor-widget elementor-widget-menu-anchor\" data-id=\"48604db\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"menu-anchor.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-menu-anchor\" id=\"practical-framework-mdt\"><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4a2a89b elementor-widget elementor-widget-spacer\" data-id=\"4a2a89b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"e-image-base \" data-interaction-id=\"9ddb2b4\" data-e-type=\"widget\" data-id=\"9ddb2b4\" id=\"171912\" src=\"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/cancer-biomarker-testing-scaled.jpeg?fit=2560%2C1429&amp;#038;ssl=1\" width=\"2560\" height=\"1429\" srcset=\"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/cancer-biomarker-testing-scaled.jpeg?w=2560&amp;ssl=1 2560w, https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/cancer-biomarker-testing-scaled.jpeg?resize=300%2C167&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/cancer-biomarker-testing-scaled.jpeg?resize=1024%2C572&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/cancer-biomarker-testing-scaled.jpeg?resize=768%2C429&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/cancer-biomarker-testing-scaled.jpeg?resize=1536%2C857&amp;ssl=1 1536w, https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/cancer-biomarker-testing-scaled.jpeg?resize=2048%2C1143&amp;ssl=1 2048w, https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/cancer-biomarker-testing-scaled.jpeg?w=1600&amp;ssl=1 1600w, https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/07\/cancer-biomarker-testing-scaled.jpeg?w=2400&amp;ssl=1 2400w\" alt=\"ctDNA, tissue biopsy and cancer imaging each support cancer diagnosis by answering different clinical questions together.\"\/>\t\t\t\t<div class=\"elementor-element elementor-element-4717659 elementor-widget elementor-widget-spacer\" data-id=\"4717659\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-563271d elementor-widget elementor-widget-heading\" data-id=\"563271d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">A Practical Framework for Multidisciplinary Teams<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-efa91f0 elementor-widget elementor-widget-text-editor\" data-id=\"efa91f0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Balancing liquid biopsy and tissue testing in oncology, alongside imaging, is less about choosing a winner and more about sequencing the right tool to the right question.\u00a0Reviews comparing liquid biopsy and tissue biopsy consistently reach the same conclusion: each brings strengths the other lacks<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11743551\/\">*<\/a>, and a strategy that draws on all three together captures more of the clinical picture than reliance on any single one. Framing each test by the specific question it is meant to answer before ordering it, rather than by habit or convenience, helps tumour boards avoid redundant testing and reduces the risk of a genuinely informative result being overlooked.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9d9854b elementor-widget elementor-widget-text-editor\" data-id=\"9d9854b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>What does that decision-making process look like in your own practice, particularly when results from these tools point in different directions? Share your experience in the comments below. If you would like to continue contributing physician perspectives on questions like this one, the Oncology Focus community at M3 Global Research welcomes your input.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4de7ec7 elementor-widget elementor-widget-text-editor\" data-id=\"4de7ec7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p class=\"PDq2pG_selectionAnchorContainer\" data-start=\"603\" data-end=\"718\">When tissue testing, ctDNA, and imaging point in different directions, what guides your next clinical decision? Share your perspective in the comments below.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7892195 elementor-widget elementor-widget-text-editor\" data-id=\"7892195\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>If you are not yet registered with M3 Global Research, <a href=\"http:\/\/m3gr.io\/BBFPFBD\">register here<\/a> to access healthcare market research studies matched to your specialty and professional profile.<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3138c4c elementor-share-buttons--view-icon elementor-share-buttons--skin-minimal elementor-share-buttons--shape-circle elementor-share-buttons--color-custom elementor-grid-0 elementor-widget elementor-widget-share-buttons\" data-id=\"3138c4c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"share-buttons.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-grid\" role=\"list\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t\t<div class=\"elementor-share-btn elementor-share-btn_email\" role=\"button\" tabindex=\"0\" aria-label=\"Share on email\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-share-btn__icon\">\n\t\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-envelope\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M502.3 190.8c3.9-3.1 9.7-.2 9.7 4.7V400c0 26.5-21.5 48-48 48H48c-26.5 0-48-21.5-48-48V195.6c0-5 5.7-7.8 9.7-4.7 22.4 17.4 52.1 39.5 154.1 113.6 21.1 15.4 56.7 47.8 92.2 47.6 35.7.3 72-32.8 92.3-47.6 102-74.1 131.6-96.3 154-113.7zM256 320c23.2.4 56.6-29.2 73.4-41.4 132.7-96.3 142.8-104.7 173.4-128.7 5.8-4.5 9.2-11.5 9.2-18.9v-19c0-26.5-21.5-48-48-48H48C21.5 64 0 85.5 0 112v19c0 7.4 3.4 14.3 9.2 18.9 30.6 23.9 40.7 32.4 173.4 128.7 16.8 12.2 50.2 41.8 73.4 41.4z\"><\/path><\/svg>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t\t<div class=\"elementor-share-btn elementor-share-btn_whatsapp\" role=\"button\" tabindex=\"0\" aria-label=\"Share on whatsapp\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-share-btn__icon\">\n\t\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fab-whatsapp\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M380.9 97.1C339 55.1 283.2 32 223.9 32c-122.4 0-222 99.6-222 222 0 39.1 10.2 77.3 29.6 111L0 480l117.7-30.9c32.4 17.7 68.9 27 106.1 27h.1c122.3 0 224.1-99.6 224.1-222 0-59.3-25.2-115-67.1-157zm-157 341.6c-33.2 0-65.7-8.9-94-25.7l-6.7-4-69.8 18.3L72 359.2l-4.4-7c-18.5-29.4-28.2-63.3-28.2-98.2 0-101.7 82.8-184.5 184.6-184.5 49.3 0 95.6 19.2 130.4 54.1 34.8 34.9 56.2 81.2 56.1 130.5 0 101.8-84.9 184.6-186.6 184.6zm101.2-138.2c-5.5-2.8-32.8-16.2-37.9-18-5.1-1.9-8.8-2.8-12.5 2.8-3.7 5.6-14.3 18-17.6 21.8-3.2 3.7-6.5 4.2-12 1.4-32.6-16.3-54-29.1-75.5-66-5.7-9.8 5.7-9.1 16.3-30.3 1.8-3.7.9-6.9-.5-9.7-1.4-2.8-12.5-30.1-17.1-41.2-4.5-10.8-9.1-9.3-12.5-9.5-3.2-.2-6.9-.2-10.6-.2-3.7 0-9.7 1.4-14.8 6.9-5.1 5.6-19.4 19-19.4 46.3 0 27.3 19.9 53.7 22.6 57.4 2.8 3.7 39.1 59.7 94.8 83.8 35.2 15.2 49 16.5 66.6 13.9 10.7-1.6 32.8-13.4 37.4-26.4 4.6-13 4.6-24.1 3.2-26.4-1.3-2.5-5-3.9-10.5-6.6z\"><\/path><\/svg>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t\t<div class=\"elementor-share-btn elementor-share-btn_linkedin\" role=\"button\" tabindex=\"0\" aria-label=\"Share on linkedin\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-share-btn__icon\">\n\t\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fab-linkedin\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3zM135.4 416H69V202.2h66.5V416zm-33.2-243c-21.3 0-38.5-17.3-38.5-38.5S80.9 96 102.2 96c21.2 0 38.5 17.3 38.5 38.5 0 21.3-17.2 38.5-38.5 38.5zm282.1 243h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9V416z\"><\/path><\/svg>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t\t<div class=\"elementor-share-btn elementor-share-btn_facebook\" role=\"button\" tabindex=\"0\" aria-label=\"Share on facebook\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-share-btn__icon\">\n\t\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fab-facebook\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256C504 119 393 8 256 8S8 119 8 256c0 123.78 90.69 226.38 209.25 245V327.69h-63V256h63v-54.64c0-62.15 37-96.48 93.67-96.48 27.14 0 55.52 4.84 55.52 4.84v61h-31.28c-30.8 0-40.41 19.12-40.41 38.73V256h68.78l-11 71.69h-57.78V501C413.31 482.38 504 379.78 504 256z\"><\/path><\/svg>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t\t<div class=\"elementor-share-btn elementor-share-btn_twitter\" role=\"button\" tabindex=\"0\" aria-label=\"Share on twitter\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-share-btn__icon\">\n\t\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fab-twitter\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z\"><\/path><\/svg>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t\t<div class=\"elementor-share-btn elementor-share-btn_pinterest\" role=\"button\" tabindex=\"0\" aria-label=\"Share on pinterest\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-share-btn__icon\">\n\t\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fab-pinterest\" viewBox=\"0 0 496 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M496 256c0 137-111 248-248 248-25.6 0-50.2-3.9-73.4-11.1 10.1-16.5 25.2-43.5 30.8-65 3-11.6 15.4-59 15.4-59 8.1 15.4 31.7 28.5 56.8 28.5 74.8 0 128.7-68.8 128.7-154.3 0-81.9-66.9-143.2-152.9-143.2-107 0-163.9 71.8-163.9 150.1 0 36.4 19.4 81.7 50.3 96.1 4.7 2.2 7.2 1.2 8.3-3.3.8-3.4 5-20.3 6.9-28.1.6-2.5.3-4.7-1.7-7.1-10.1-12.5-18.3-35.3-18.3-56.6 0-54.7 41.4-107.6 112-107.6 60.9 0 103.6 41.5 103.6 100.9 0 67.1-33.9 113.6-78 113.6-24.3 0-42.6-20.1-36.7-44.8 7-29.5 20.5-61.3 20.5-82.6 0-19-10.2-34.9-31.4-34.9-24.9 0-44.9 25.7-44.9 60.2 0 22 7.4 36.8 7.4 36.8s-24.5 103.8-29 123.2c-5 21.4-3 51.6-.9 71.2C65.4 450.9 0 361.1 0 256 0 119 111 8 248 8s248 111 248 248z\"><\/path><\/svg>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t\t<div class=\"elementor-share-btn elementor-share-btn_xing\" role=\"button\" tabindex=\"0\" aria-label=\"Share on xing\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-share-btn__icon\">\n\t\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fab-xing\" viewBox=\"0 0 384 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M162.7 210c-1.8 3.3-25.2 44.4-70.1 123.5-4.9 8.3-10.8 12.5-17.7 12.5H9.8c-7.7 0-12.1-7.5-8.5-14.4l69-121.3c.2 0 .2-.1 0-.3l-43.9-75.6c-4.3-7.8.3-14.1 8.5-14.1H100c7.3 0 13.3 4.1 18 12.2l44.7 77.5zM382.6 46.1l-144 253v.3L330.2 466c3.9 7.1.2 14.1-8.5 14.1h-65.2c-7.6 0-13.6-4-18-12.2l-92.4-168.5c3.3-5.8 51.5-90.8 144.8-255.2 4.6-8.1 10.4-12.2 17.5-12.2h65.7c8 0 12.3 6.7 8.5 14.1z\"><\/path><\/svg>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>ctDNA, tissue biopsy and cancer imaging each support cancer diagnosis by answering different clinical questions together.<\/p>\n","protected":false},"author":11,"featured_media":171867,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_eb_attr":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[8201],"tags":[2875],"class_list":["post-171804","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-physician-hub","tag-oncology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.9 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Using ctDNA, Tissue Testing, and Imaging Together<\/title>\n<meta name=\"description\" content=\"ctDNA, tissue biopsy and cancer imaging each support cancer diagnosis by answering different clinical questions together.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Three Tools, Different Questions: Using ctDNA, Tissue Testing, and Imaging Together\" \/>\n<meta property=\"og:description\" content=\"ctDNA, tissue biopsy and cancer imaging each support cancer diagnosis by answering different clinical questions together.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/\" \/>\n<meta property=\"og:site_name\" content=\"M3 Global Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/en-gb.facebook.com\/M3GlobalResearch\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-01T11:42:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-01T15:08:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ctDNA-2-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1429\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Admin B.\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@M3GR_Community\" \/>\n<meta name=\"twitter:site\" content=\"@M3GR_Community\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin B.\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/three-tools-using-ctdna-tissue-testing-imaging-together\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/three-tools-using-ctdna-tissue-testing-imaging-together\\\/\"},\"author\":{\"name\":\"Admin B.\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/person\\\/2694d930280885a6f8adfd3c7090c10b\"},\"headline\":\"Three Tools, Different Questions: Using ctDNA, Tissue Testing, and Imaging Together\",\"datePublished\":\"2026-07-01T11:42:13+00:00\",\"dateModified\":\"2026-07-01T15:08:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/three-tools-using-ctdna-tissue-testing-imaging-together\\\/\"},\"wordCount\":1507,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/three-tools-using-ctdna-tissue-testing-imaging-together\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/ctDNA-2-scaled.jpeg?fit=2560%2C1429&ssl=1\",\"keywords\":[\"oncology\"],\"articleSection\":[\"Physician Hub\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/three-tools-using-ctdna-tissue-testing-imaging-together\\\/#respond\"]}]},{\"@type\":[\"WebPage\",\"MedicalWebPage\"],\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/three-tools-using-ctdna-tissue-testing-imaging-together\\\/\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/three-tools-using-ctdna-tissue-testing-imaging-together\\\/\",\"name\":\"Using ctDNA, Tissue Testing, and Imaging Together\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/three-tools-using-ctdna-tissue-testing-imaging-together\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/three-tools-using-ctdna-tissue-testing-imaging-together\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/ctDNA-2-scaled.jpeg?fit=2560%2C1429&ssl=1\",\"datePublished\":\"2026-07-01T11:42:13+00:00\",\"dateModified\":\"2026-07-01T15:08:51+00:00\",\"description\":\"ctDNA, tissue biopsy and cancer imaging each support cancer diagnosis by answering different clinical questions together.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/three-tools-using-ctdna-tissue-testing-imaging-together\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/three-tools-using-ctdna-tissue-testing-imaging-together\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/three-tools-using-ctdna-tissue-testing-imaging-together\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/ctDNA-2-scaled.jpeg?fit=2560%2C1429&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/ctDNA-2-scaled.jpeg?fit=2560%2C1429&ssl=1\",\"width\":2560,\"height\":1429,\"caption\":\"ctDNA, tissue biopsy and cancer imaging each support cancer diagnosis by answering different clinical questions together.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/three-tools-using-ctdna-tissue-testing-imaging-together\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Three Tools, Different Questions: Using ctDNA, Tissue Testing, and Imaging Together\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/\",\"name\":\"M3 Global Research\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#organization\",\"name\":\"M3 Global Research\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":null,\"contentUrl\":null,\"width\":null,\"height\":null,\"caption\":\"M3 Global Research\"},\"image\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/en-gb.facebook.com\\\/M3GlobalResearch\\\/\",\"https:\\\/\\\/x.com\\\/M3GR_Community\",\"https:\\\/\\\/www.instagram.com\\\/m3globalresearch\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/10557915\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/person\\\/2694d930280885a6f8adfd3c7090c10b\",\"name\":\"Admin B.\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5f811bebef837ff0367d28aa777df5c8b43795cab6f9ff385cce49abb4e04a6f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5f811bebef837ff0367d28aa777df5c8b43795cab6f9ff385cce49abb4e04a6f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5f811bebef837ff0367d28aa777df5c8b43795cab6f9ff385cce49abb4e04a6f?s=96&d=mm&r=g\",\"caption\":\"Admin B.\"},\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/author\\\/admin-b\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Using ctDNA, Tissue Testing, and Imaging Together","description":"ctDNA, tissue biopsy and cancer imaging each support cancer diagnosis by answering different clinical questions together.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/","og_locale":"en_US","og_type":"article","og_title":"Three Tools, Different Questions: Using ctDNA, Tissue Testing, and Imaging Together","og_description":"ctDNA, tissue biopsy and cancer imaging each support cancer diagnosis by answering different clinical questions together.","og_url":"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/","og_site_name":"M3 Global Research","article_publisher":"https:\/\/en-gb.facebook.com\/M3GlobalResearch\/","article_published_time":"2026-07-01T11:42:13+00:00","article_modified_time":"2026-07-01T15:08:51+00:00","og_image":[{"width":2560,"height":1429,"url":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ctDNA-2-scaled.jpeg","type":"image\/jpeg"}],"author":"Admin B.","twitter_card":"summary_large_image","twitter_creator":"@M3GR_Community","twitter_site":"@M3GR_Community","twitter_misc":{"Written by":"Admin B.","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/#article","isPartOf":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/"},"author":{"name":"Admin B.","@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/person\/2694d930280885a6f8adfd3c7090c10b"},"headline":"Three Tools, Different Questions: Using ctDNA, Tissue Testing, and Imaging Together","datePublished":"2026-07-01T11:42:13+00:00","dateModified":"2026-07-01T15:08:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/"},"wordCount":1507,"commentCount":0,"publisher":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ctDNA-2-scaled.jpeg?fit=2560%2C1429&ssl=1","keywords":["oncology"],"articleSection":["Physician Hub"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/#respond"]}]},{"@type":["WebPage","MedicalWebPage"],"@id":"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/","url":"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/","name":"Using ctDNA, Tissue Testing, and Imaging Together","isPartOf":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/#primaryimage"},"image":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ctDNA-2-scaled.jpeg?fit=2560%2C1429&ssl=1","datePublished":"2026-07-01T11:42:13+00:00","dateModified":"2026-07-01T15:08:51+00:00","description":"ctDNA, tissue biopsy and cancer imaging each support cancer diagnosis by answering different clinical questions together.","breadcrumb":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/#primaryimage","url":"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ctDNA-2-scaled.jpeg?fit=2560%2C1429&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ctDNA-2-scaled.jpeg?fit=2560%2C1429&ssl=1","width":2560,"height":1429,"caption":"ctDNA, tissue biopsy and cancer imaging each support cancer diagnosis by answering different clinical questions together."},{"@type":"BreadcrumbList","@id":"https:\/\/www.m3globalresearch.com\/blog\/three-tools-using-ctdna-tissue-testing-imaging-together\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.m3globalresearch.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Three Tools, Different Questions: Using ctDNA, Tissue Testing, and Imaging Together"}]},{"@type":"WebSite","@id":"https:\/\/www.m3globalresearch.com\/blog\/#website","url":"https:\/\/www.m3globalresearch.com\/blog\/","name":"M3 Global Research","description":"","publisher":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.m3globalresearch.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.m3globalresearch.com\/blog\/#organization","name":"M3 Global Research","url":"https:\/\/www.m3globalresearch.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/logo\/image\/","url":null,"contentUrl":null,"width":null,"height":null,"caption":"M3 Global Research"},"image":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/en-gb.facebook.com\/M3GlobalResearch\/","https:\/\/x.com\/M3GR_Community","https:\/\/www.instagram.com\/m3globalresearch","https:\/\/www.linkedin.com\/company\/10557915"]},{"@type":"Person","@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/person\/2694d930280885a6f8adfd3c7090c10b","name":"Admin B.","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/5f811bebef837ff0367d28aa777df5c8b43795cab6f9ff385cce49abb4e04a6f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5f811bebef837ff0367d28aa777df5c8b43795cab6f9ff385cce49abb4e04a6f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5f811bebef837ff0367d28aa777df5c8b43795cab6f9ff385cce49abb4e04a6f?s=96&d=mm&r=g","caption":"Admin B."},"url":"https:\/\/www.m3globalresearch.com\/blog\/author\/admin-b\/"}]}},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ctDNA-2-scaled.jpeg?fit=2560%2C1429&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts\/171804","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/comments?post=171804"}],"version-history":[{"count":68,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts\/171804\/revisions"}],"predecessor-version":[{"id":171949,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts\/171804\/revisions\/171949"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/media\/171867"}],"wp:attachment":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/media?parent=171804"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/categories?post=171804"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/tags?post=171804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}